Work-stream 2 – led by Dr Jacqueline Stair, with support from Dr Stewart Kirton, Professor Mire Zloh (all UH), with Professor Raffaele Giorgetti (Italy)

Slides:



Advertisements
Similar presentations
Opportunities for higher education institutions and other bodies.
Advertisements

Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
European Partnership for Action Against Cancer (EPAAC)
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
Modelling the impact of service innovation in stroke care Information and Communication Research Initiative 2 (ICTRI 2) Research Seminar 15 February 2007.
DISSEMINATION / VALORISATION PLAN AND ACTIVITIES PRESENTED BY DR SHYAM PATIAR.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
MASH Understanding Multi-Agency Safeguarding Hubs 1.
EU Public Health Programme Strand 1: Improve information system Establish Working Parties: 1.Lifestyle and other health determinants 2.Morbidity.
Engineering & Physical Sciences Research Council.
Tim Pfeiffer-Gerschel, DBDD Dubrovnik, Jan 2008CARDS EWS CARDS 2004, Component 4 Early Warning System Tim Pfeiffer-Gerschel National Focal Point.
The Programme is funded by Erasmus+ under
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Aldona Kowalczyk-Rębiś Agnieszka Kowalska
1 OPHS FOUNDATIONAL STANDARD BOH Section Meeting February 11, 2011.
Case studies: online health and telemedicine Professor Peter C Smith Professor of Health Policy, Imperial College Business School, London.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Digital Curator Vocational Education Europe Kate Fernie MDR Partners This project has been funded with support from the European Commission'
Clinical Risk Unit University College London International Perspectives Feedback from the review board Charles Vincent Clinical Risk Unit University College.
For more information, visit : or contact: Summary PROMOVAX is a 3-year EU-funded project.
PICASA University of Roehampton, London
1 WERT: WP 5 RG EVANS ASSOCIATES November 2010 Aim To pilot and evaluate the content and context of the course material with target groups To help women.
MESH UK Workshop 19 October 2006 Introduction Dr Paul Gilliland Marine Policy Adviser and MESH Partner Lead Natural England.
Components of a national drug prevention system Ms. UNODC.
Supporting the new responsibility for health Progress Towards Health Ageing in Europe EoE LGA Member Master class Cllr Alan Murray Elspeth Gibson.
Carol Brayne on behalf of the executive group 10 October 2013 CLAHRC East of England Dementia, Frailty, End of Life Care Theme.
Commissioning Update – Specifications, Performance and Funding Ben Seale January 2012.
European Standards on Confidentiality and Privacy in Healthcare Dr Colin M Harper Division of Psychiatry & Neuroscience Queen’s University.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
Exploitation Seminar , Budapest Presentation of European Family Set.
S.A.F.E Situation Awareness For Everyone
European Energy Research Alliance Cork April 12 Henry Jeffrey Institute for Energy Systems EERA and EERA Ocean Energy.
LOCAL PASS A Local approach towards the reduction of PsychoActive Substance uSe Renée Otte February 5, 2015.
IMPACT 3-5th November 20044th IMPACT Project Workshop Zaragoza 1 Investigation of extreme flood Processes and uncertainty IMPACT Investigation of Extreme.
LIFELONG GUIDANCE SYSTEMS: COMMON EUROPEAN REFERENCE TOOLS ELGPN PEER LEARNING ACTIVITY WP2 Prague April 2008 Dr John McCarthy, Director International.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
The Need for Education on Novel Psychoactive Substances (“Legal Highs”) amongst Undergraduate Health Care Professionals Safia Akhtar
September 2006 eViP By Chara Balasubramaniam on behalf of the eViP team St George’s University of London The story so far Introduction.
Date, location Open Access policy guidelines for research institutions Name Logo area.
Strengthening the commitment
PHE Local Intelligence Contribution David Meechan, Director for Knowledge & Intelligence (East Midlands), Public Health England.
EVIDENCE BASED POLICY RECOMMENDATIONS – TAKE AWAY LESSONS ON HOW TO PROGRESS EFFECTIVE ALCOHOL EDUCATION BETSY THOM Drug and Alcohol Research Centre MIDDLESEX.
Website: eumadness.eu Novel Psychoactive Substances (NPS) - teaching of undergraduate healthcare professionals and educating the educators Society for.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
5 Project funded by the Euro- Mediterranean Regional Programme for Local Water Management of the European Union DEVELOPMENT OF TOOLS AND GUIDELINES FOR.
Promoting physical activity for children and young people Schools and colleges Implementing NICE guidance 2009 NICE public health guidance 17.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
New Psychoactive Substances: an overview of the evidence Isla Wallace, Social Researcher Drugs Research Team
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
EU-HCWM “Developing an EU Standardised Approach to Vocational Educational Training Awards in Healthcare Waste Management” Project No LLP UK-LEONARDO-LNW.
LeHo Learning at Home and in the Hospital Presentation for Governors Presentation by George Sfougaras Children’s Hospital School Leicester.
Exploitation means to use and benefit from something. For Erasmus+ this means maximising the potential of the funded activities, so that the results are.
Monitoring Visit to NatRisk Project
Kick Off Meeting Largs, Scotland
European Forensic Educational Network ERASMUS+ Strategic Partnerships project EFEN.
Dissemination and communication – wp5
Baltic Regional Conference, , Riga
European-Comparative Effectiveness Research on online Depression Treatment E-COMPARED is funded by the European Community’s Seventh Framework.
WHO minimum public health data set on prison health
Higher Education Institution (HEI) Challenge for patient supported quality improvement and education in health and social care Pauline Mountain M.B.E.
EUREKA project Overview
Role & Responsibilities: Surrey Safeguarding Children Board (SSCB)
A European network to map Health Literacy pedagogy across Europe: an emerging bid for Grundtvig partnership funding Gill Rowlands Chair, Health Literacy.
The Programme is funded by Erasmus+ under
CAPITAL its-elearning.eu
Raising the bar Meeting Europe’s future challenges
Scottish Cancer Registry and Intelligence Service (SCRIS)
Presentation transcript:

Work-stream 2 – led by Dr Jacqueline Stair, with support from Dr Stewart Kirton, Professor Mire Zloh (all UH), with Professor Raffaele Giorgetti (Italy) 1.To develop computational approaches which exploit data from both laboratory based and handheld Raman spectroscopy. 2.Computational approaches will be used to estimate or predict information regarding NPS. 3.This work is linked with Work-streams 1 and 3. John Corkery (University of Hertfordshire)   Christine Goodair (St George’s,University of London)   Based on the rapid increase in the number of Novel Psychoactive Substances (EMCDDA, 2013) and the continuing high prevalence of drug-related deaths (EU, 2012), the European Commission recently awarded funding to a multi-institutional partnership across five countries led by the University of Hertfordshire, UK, to undertake a project looking at NPS. Background Work-streams 1-4 Work-stream 1 – led by John Corkery; collaborators from UK, Hungary, Italy This involves collecting a range of information from providers in several countries relating to individuals who have reported using NPSs or died from such use. Recording of such data allows ascertainment of groups exposed to specific NPSs and their associated harms, helping to formulate improved approaches to identification and recording of deaths and ‘near misses’ linked to NPS use. Data from these reports will inform the choice of compounds to be investigated in WS2 and WS3, and will be disseminated via WS4, with appropriate interpretation and guidance, to different stake-holders including those involved in health professionals’ training. Work-stream 3 – led by Dr Colin Davidson, St George’s University of London (SGUL), with Professor Gaetano Di Chiara (Italy) and Professor Emilio Ambrosio (Spain) 1.in vitro neurochemical testing of NPS in rat brain slices, aorta 2.in vivo neurochemical testing in whole rats 3.in vivo behavioural testing in rat models of drug abuse The most interesting of the NPSs, determined by these in vitro assays, will be examined using in vivo dopamine and 5-HT efflux in the accumbens using microdialysis. Long-term effects of selected NPS on rodent cognitive function will be examined as well. To monitor, test, profile, and feed back into education and prevention knowledge relating to the types of NPS emerging, their associated characteristics and potential harms through 4 integrated work-streams Aim To develop integrated monitoring and profiling of Novel Psychoactive Substances (NPS) in Europe in order to prevent health harms and update relevant professionals. Objective EUMADN ESS EUropean-wide, Monitoring, Analysis and knowledge Dissemination on Novel/ Emerging pSychoactiveSwww.eumadness.eu European Commission – funding awarded of € 635,215. Started 1 April 2014 & lasts 24 months. Principal Investigator – Professor Fabrizio Schifano, University of Hertfordshire 12 European Partner Institutions across 5 countries The Project Work-stream 4 – led by Dr Colin Davidson with Mrs Christine Goodair (SGUL), with partners in Scotland (Professor Simon Maxwell), Germany (Professor Norbert Scherbaum), Italy (Professor Giovanni Martinotti and Professor Raffaele Giorgetti), and Spain (Professor Magi Farré) 1.Ask healthcare educationalists what they know/teach about NPS 2.Create learning resources in multiple languages for healthcare professionals 3.Disseminate resources 4.Data from works-streams 1-3 feeds into the WS4. Reduction in harms and adverse consequences of use, including death, through enhanced knowledge on the part of health professionals providing interventions, delivering services and treatment. Beneficiaries: Emergency Services, paramedics, police, health care professionals, officers/coronial staff, medico-legal professionals, educators, national and EU authorities (e.g. National Focal Points, EMCDDA) Anticipated Benefits Peer-reviewed journal articles Multi-lingual Factsheets PowerPoint Presentations for teaching Website (updated regularly and offering membership) Expected Outputs Apps; interactive online Q&As Local Scientific/Educational meetings poster/Oral communications School visits to discuss NPS Seminars/Scientific meetings This project is funded by the Drug Prevention and Information Programme of the European Union and led by the University of Hertfordshire